首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Phosphatase of Regenerating Liver 2 (PRL2) Deficiency Impairs Kit Signaling and Spermatogenesis
【2h】

Phosphatase of Regenerating Liver 2 (PRL2) Deficiency Impairs Kit Signaling and Spermatogenesis

机译:再生肝2(PRL2)缺乏的磷酸酶损害试剂盒信号和生精。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Phosphatase of Regenerating Liver (PRL) proteins promote cell signaling and are oncogenic when overexpressed. However, our understanding of PRL function came primarily from studies with cultured cell lines aberrantly or ectopically expressing PRLs. To define the physiological roles of the PRLs, we generated PRL2 knock-out mice to study the effects of PRL deletion in a genetically controlled, organismal model. PRL2-deficient male mice exhibit testicular hypotrophy and impaired spermatogenesis, leading to decreased reproductive capacity. Mechanistically, PRL2 deficiency results in elevated PTEN level in the testis, which attenuates the Kit-PI3K-Akt pathway, resulting in increased germ cell apoptosis. Conversely, increased PRL2 expression in GC-1 cells reduces PTEN level and promotes Akt activation. Our analyses of PRL2-deficient animals suggest that PRL2 is required for spermatogenesis during testis development. The study also reveals that PRL2 promotes Kit-mediated PI3K/Akt signaling by reducing the level of PTEN that normally antagonizes the pathway. Given the strong cancer susceptibility to subtle variations in PTEN level, the ability of PRL2 to repress PTEN expression qualifies it as an oncogene and a novel target for developing anti-cancer agents.
机译:再生肝磷酸酶(PRL)蛋白促进细胞信号传导,过表达时具有致癌性。但是,我们对PRL功能的理解主要来自对培养的细胞系异常或异位表达PRL的研究。为了定义PRL的生理作用,我们产生了PRL2基因敲除小鼠,以研究在遗传控制的生物模型中PRL缺失的影响。 PRL2缺陷的雄性小鼠表现出睾丸营养不良和精子发生受损,导致生殖能力下降。从机制上讲,PRL2缺乏会导致睾丸中PTEN水平升高,从而削弱Kit-PI3K-Akt通路,从而导致生殖细胞凋亡增加。相反,GC-1细胞中PRL2表达的增加会降低PTEN水平并促进Akt激活。我们对PRL2缺陷动物的分析表明,睾丸发育过程中精子发生需要PRL2。该研究还揭示了PRL2通过降低通常拮抗该途径的PTEN的水平来促进Kit介导的PI3K / Akt信号传导。鉴于对PTEN水平细微变化的强烈癌症敏感性,PRL2抑制PTEN表达的能力使其成为癌基因和开发抗癌药物的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号